▪ The pursuit of the ideal tumor marker has generated many tests for use in the diagnosis
and management of cancer, several of which are now widely available. Tumor markers have …

Introduction: Patients treated for ovarian cancer with curative intent receive an intensive
follow-up program in the years after treatment. However, the aimed improved survival …

The levels of CA125, CA19. 9, CA15. 3 CA72. 4, and TATI were serially measured during
and after chemotherapy in 43 patients with epithelial ovarian cancer having elevated …

Monthly serum CA 125 determinations were used for monitoring of 33 patients with
advanced nonmucinous epithelial ovarian cancer during the follow-up after the primary …

Monoclonal antibodies against an ovarian tumor cell line, OC-3-VGH, were generated using
modified hybridoma technology. Among the seven that were selected for their high …

The clinical usefulness of any imaging modality can be best determined by assessing the
impact on decisions regarding diagnosis, disease treatment, and effect on patient outcome …

In an attempt to establish a blood-based biochemical index for diagnosis of cervical cancer
and treatment monitoring of patients suffering from the disease, serum levels of total sialic …

Ovarian cancer is the sixth most common neoplasm among women worldwide and accounts
for 4.3% of all female malignancies [1]. The highest incidence rates are reported from …

The monitoring value of three tumor markers—CA-125, lipid-associated sialic acid (LSA),
and NB 70 K—alone and in combination has been studied in 152 patients with invasive …

The role of cytoreductive surgery is well established in patients with primary ovarian
carcinoma. Minimal residual disease translates to improved response to adjuvant treatment …